Bhupinder Singh

Co-founded Renibus Therapeutics as a Director of the company. Bhupinder Singh, MD is a nephrologist with an extensive background in clinical development and medical affairs. Dr. Singh currently serves as a member of the scientific advisory board for PatienTrials, Aseptiscope, Vice President of Clinical Development and Medical Affairs at Allakos, and a clinical professor of medicine in the Division of Nephrology, Department of Medicine at the University of California, Irvine.

He was previously Executive Director, Research and Medical Affairs at ZS Pharma (AstraZeneca), Chief Medical Officer at Apex Research of Riverside, founder of the Southwest Kidney Institute, and has held several medical directors and nephrologist appointments, in addition to publishing a multitude of peer-reviewed papers and abstracts at scientific meetings in the field of nephrology.